How Long Does Lorazepam Last and Stay in Your System?

Lorazepam’s noticeable calming and sedative effects typically last around six to eight hours, but the drug lingers in your body much longer than that. Its elimination half-life averages about 14 hours, meaning it takes roughly three days for a single dose to clear your bloodstream almost entirely. Sensitive lab tests can pick up traces in urine for six days or more, and hair analysis can reveal use months later. How long the drug truly “lasts” depends on whether you mean its therapeutic effects, its presence in blood, or its detectability on a drug screen, and the answer is different for each.

How Quickly Lorazepam Takes Effect

When you swallow a lorazepam tablet, the drug absorbs rapidly through the gut. In a study of single 4-mg oral doses, absorption half-life averaged about 25 minutes, and peak plasma concentrations were reached within about two to two-and-a-half hours.¹ Most people start feeling calmer within 15 to 30 minutes, even before blood levels have fully peaked, because the drug begins crossing into the brain almost immediately after it enters the bloodstream.

The route of administration changes the timeline only slightly. Intramuscular injection produces peak plasma levels a bit faster, around 1.15 hours, while oral and sublingual routes reach their peaks at roughly 2.3 hours. Importantly, bioavailability is essentially 100 percent regardless of whether you take lorazepam by mouth, under the tongue, or by injection, and the elimination half-life stays the same across all routes.² So while the onset might be slightly quicker with an injection in an emergency room, the total amount of drug your body has to process afterward is essentially the same.

How Long the Effects Actually Last

There is a meaningful gap between how long lorazepam stays in your blood and how long you feel its effects. The drug’s sedative and anti-anxiety action peaks a bit after blood levels do, because lorazepam needs time to equilibrate from the bloodstream into brain tissue. Pharmacokinetic-pharmacodynamic modeling puts this equilibration half-time at roughly 25 minutes, which explains why the strongest sedation often hits about an hour or so after the blood concentration peaks.³

Most clinicians consider lorazepam’s practical effect window to be six to eight hours for anxiety relief and sedation. That fits with the drug’s intermediate half-life of about 14 hours: after one half-life, blood levels have dropped by half, and the sedation and anxiolytic effect have faded noticeably. But residual drowsiness, mild cognitive slowing, and impaired coordination can extend beyond the window where you feel actively sedated. This is why doctors typically advise against driving or operating heavy machinery for at least eight hours after a dose, and longer for some people.

Your brain also adapts to the drug surprisingly fast. Even within a single dose, studies measuring reaction time and cognitive performance show the development of acute tolerance: performance starts recovering before the drug has left your system.⁴ That rapid within-dose tolerance is one reason the sedation wears off while blood levels are still substantial. It is also why people who take lorazepam regularly may notice it seems to “stop working” sooner over time.

How Your Body Breaks Down and Eliminates Lorazepam

Unlike many other benzodiazepines, lorazepam has a relatively clean metabolic pathway. It does not pass through the liver’s cytochrome P450 enzyme system to any significant degree. Instead, the liver attaches a sugar molecule to lorazepam in a process called glucuronidation, converting it to lorazepam glucuronide, an inactive compound that your kidneys then flush out.⁵ The specific enzymes doing the heavy lifting are a family of proteins called UGTs, mainly UGT2B7 and UGT2B15.

This matters for two practical reasons. First, because lorazepam skips the P450 system, it has fewer drug interactions than benzodiazepines like diazepam or alprazolam, which rely heavily on that system. Second, it means lorazepam is often considered safer in people with liver disease, since glucuronidation tends to be preserved longer than the P450-mediated oxidation reactions that are more vulnerable to liver damage.

Once the glucuronide is formed, it is water-soluble and exits through the kidneys. About 64 percent of a dose ends up in the urine as the glucuronide metabolite. Only around 2 percent of the original lorazepam is excreted unchanged, and fecal excretion contributes almost nothing.⁶ In people with severely impaired kidneys, the glucuronide metabolite can accumulate in the blood for days after a single dose, even though the metabolite itself is inactive and nontoxic.⁷

Detection Windows by Sample Type

How long lorazepam shows up on a drug test depends entirely on what kind of sample is being tested. Urine, blood, and hair each tell a different story about when you last took the drug.

Urine

Urine is the most commonly used specimen for benzodiazepine screening, and lorazepam has a longer detection window there than most people expect. In a controlled study where volunteers took a single 2.5-mg dose, urine tested positive for lorazepam for the full 144 hours (six days) of the collection period, with peak urine concentrations showing up about 24 hours after the dose.⁸ That was a single modest dose measured with a sensitive analytical method. Standard immunoassay screening used in workplace or clinical drug panels is less sensitive and may return to negative sooner, perhaps three to five days after a single dose, but this varies by the cutoff the lab uses.

For people taking lorazepam daily, the drug and its metabolite accumulate, and the detection window extends further. Chronic users can test positive for a week or more after their last dose. Individual factors like body fat percentage, hydration, and kidney function shift the window in either direction.

Blood and Saliva

Lorazepam is detectable in blood roughly as long as it is pharmacologically active, plus a tail. With a half-life averaging 14 hours, a single dose falls below typical analytical detection limits within about three days. Sensitive assays can detect plasma concentrations as low as 2.5 ng/ml.⁹ After that, levels are simply too low to measure reliably. Blood testing is most useful when the question is whether someone is currently under the influence, not whether they took a dose last week.

Oral fluid (saliva) testing has a shorter detection window still. In the same study that tracked urine for six days, oral fluid was collected over only eight hours, and the researchers treated it as a narrower detection medium. Saliva testing can confirm very recent use but is not useful for looking back more than about a day.

Hair

Hair analysis occupies the other end of the spectrum. Once lorazepam or its metabolites are incorporated into a growing hair strand, they stay there essentially forever, until the hair is cut off. Because head hair grows roughly one centimeter per month, a 3-centimeter sample clipped near the scalp captures approximately the last three months of drug exposure. In a forensic case, concentrations of lorazepam ranging from 31 to 49 pg/mg were measured along a 16-centimeter hair strand, documenting long-term use.¹⁰ These are extremely small quantities requiring specialized lab techniques, so hair testing for lorazepam is mainly used in forensic and legal settings rather than routine clinical screening.

Factors That Make Lorazepam Last Longer

The 14-hour average half-life is exactly that, an average. The actual range in healthy adults runs from about 8 to 24 hours, which means the drug could clear from one person in under two days and take nearly four days to clear from another.¹ Several factors push you toward the slow end of that range.

Age

Older adults clear lorazepam about 22 percent more slowly than younger adults. In a direct comparison, total clearance in elderly subjects was 0.77 ml/min/kg versus 0.99 ml/min/kg in younger volunteers.¹¹ Interestingly, the elimination half-life did not differ much between the two groups (about 16 hours versus 14 hours), because the elderly also distributed the drug into a slightly smaller volume. The practical upshot is that older adults maintain higher blood levels for longer, and they tend to experience more pronounced sedation and greater risk of falls. This is why geriatric dosing guidelines recommend starting at lower doses.

Genetics

Because lorazepam relies so heavily on glucuronidation, genetic variation in UGT enzymes can meaningfully alter how fast you process the drug. People who carry two copies of a particular variant of the UGT2B15 gene (the *2/*2 genotype) showed about 42 percent lower clearance compared to those with the standard genotype, and they reported greater sedation at the same dose.¹² This polymorphism is not rare; depending on the population, roughly a quarter to a third of people carry at least one copy. Routine genetic testing before prescribing lorazepam is not standard practice, but this finding helps explain why some people seem unusually sensitive to the drug while others barely notice a typical dose.

Drug Interactions

Because lorazepam avoids the P450 system, its interaction profile is shorter than that of many benzodiazepines, but it is not zero. The most well-studied interaction involves valproate, a medication used for epilepsy and bipolar disorder. When the two drugs are taken together, valproate inhibits the glucuronidation pathway and reduces lorazepam clearance by roughly 30 to 40 percent.¹³¹⁴ That effectively extends the drug’s half-life and intensifies its sedative effects. Other drugs that inhibit glucuronidation, such as probenecid, can have a similar effect, though they are studied less thoroughly with lorazepam specifically.

Alcohol deserves a separate mention. It does not change lorazepam’s pharmacokinetics in a major way, but it amplifies the sedative and respiratory-depressant effects dramatically, because both substances work on the same receptor system in the brain. The combination is dangerous regardless of how quickly either one is metabolized.

Kidney Impairment

Since lorazepam itself is metabolized in the liver, kidney disease does not directly slow the drug’s breakdown. However, the inactive glucuronide metabolite depends on the kidneys for elimination, and in people with chronic renal failure, this metabolite accumulates substantially in the blood.⁷ The metabolite is not pharmacologically active, so the accumulation does not worsen sedation, but it can confuse drug monitoring and extend the window of positive urine tests.

Withdrawal and Rebound Symptoms

How long lorazepam stays in your system also shapes when withdrawal symptoms appear if you stop the drug abruptly after regular use. Because lorazepam is an intermediate-half-life benzodiazepine, rebound anxiety and insomnia typically emerge within one to four days of the last dose.¹⁵ That timing is faster than what you would see with long-acting benzodiazepines like diazepam, where the drug’s metabolites can take a week or more to fall to low levels, delaying the onset of withdrawal.

The severity of withdrawal depends on the dose, the duration of use, and how abruptly you stop. Short-lived rebound symptoms, where anxiety or insomnia temporarily worsens beyond pre-treatment levels, are the most common pattern. A smaller subset of people, especially those who have taken high doses for months, experience a more prolonged withdrawal syndrome that can include sensory hypersensitivity, muscle tension, and perceptual disturbances lasting weeks. This is one of the main reasons doctors taper the dose gradually rather than stopping it all at once.

Lorazepam During Pregnancy and Breastfeeding

Lorazepam crosses the placenta, though it does so more slowly than diazepam.¹⁶ The clinical significance of that slower transfer is uncertain, and lorazepam is still generally avoided during pregnancy when possible, especially in the first trimester. Use near delivery can cause the newborn to be floppy and sedated, and if the mother has been taking it regularly, the baby may show signs of benzodiazepine withdrawal after birth.

Lorazepam also appears in breast milk. At standard clinical doses, the amount reaching the infant is small and unlikely to cause problems, but high or frequent maternal doses raise the risk of sedation in a nursing baby. Newborns are particularly vulnerable because their immature livers glucuronidate drugs much more slowly than adult livers, effectively extending the drug’s half-life in the infant’s body far beyond what you would see in an adult.

Why Lorazepam Is Considered “Intermediate” Among Benzodiazepines

Benzodiazepines span a huge range of half-lives. Some ultra-short-acting compounds are essentially gone within a few hours, while others like diazepam have active metabolites that persist for days. Lorazepam sits in the middle. Its half-life of about 14 hours, combined with the fact that its only metabolite is inactive, gives it a relatively predictable and moderate duration of action. That intermediate profile is partly why it became one of the most widely prescribed benzodiazepines in hospital and outpatient settings: it is long enough to cover a full night of sleep or a sustained episode of anxiety, short enough that accumulation with daily dosing is modest, and its glucuronidation pathway makes it more predictable in patients with liver problems or those taking multiple medications.

This metabolic simplicity also means that the individual variation in how long lorazepam lasts tends to come from a smaller number of factors than it does for more complex benzodiazepines. If you know a person’s age, rough kidney function, and whether they are taking a glucuronidation inhibitor, you can predict their lorazepam clearance fairly well. That is a level of predictability prescribers appreciate, even if it does not eliminate the wide individual range entirely.